Publications by authors named "Craig Eagle"

Claim this Profile
C
Cost-effectiveness of blood-based colorectal cancer screening - a simulation model incorporating real-world longitudinal adherence.
Elifnur Yay Donderici, Shaun P Forbes, Nicole J Zhang, Gregory Schafer, Victoria M Raymond, Craig Eagle

Expert Rev Pharmacoecon Outcomes Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comments on "Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision".
Amar K Das, Craig Eagle, AmirAli Talasaz

Gastroenterology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population health outcomes of blood-based screening for colorectal cancer in comparison to current screening modalities: insights from a discrete-event simulation model incorporating longitudinal adherence.
Shaun P Forbes, Elifnur Yay Donderici, Nicole Zhang, Behnam Sharif, Gabriel Tremblay, Craig Eagle

J Med Econ· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening.
Daniel C Chung, Darrell M Gray, Harminder Singh, Rachel B Issaka, Victoria M Raymond, Craig Eagle

N Engl J Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The APC and PreSAP trials: a post hoc noninferiority analysis using a comprehensive new measure for gastrointestinal tract injury in 2 randomized, double-blind studies comparing celecoxib and placebo.
Nadir Arber, David Lieberman, Timothy C Wang, Richard Zhang, George H Sands, Craig Eagle

Clin Ther· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer.
Anita L Sabichi, J Jack Lee, H Barton Grossman, Suyu Liu, Ellen Richmond, Craig Eagle

Cancer Prev Res (Phila)· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and outcomes in familial adenomatous polyposis patients with a long-term treatment of celecoxib: a matched cohort study.
Kui Huang, Lia P Gutierrez, Steffen Bülow, Steven Gallinger, Antoni Castells, Craig J Eagle

Fam Cancer· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year analysis of the prevention of colorectal sporadic adenomatous polyps trial.
Nadir Arber, Julius Spicak, István Rácz, Miroslav Zavoral, Aurora Breazna, Craig J Eagle

Am J Gastroenterol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and efficacy of celecoxib in children with familial adenomatous polyposis.
Patrick M Lynch, Gregory D Ayers, Ernie Hawk, Ellen Richmond, Craig Eagle

Am J Gastroenterol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial.
Monica M Bertagnolli, Meier Hsu, Ernest T Hawk, Craig J Eagle, Ann G Zauber

Cancer Prev Res (Phila)· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytochrome P450 2C9 variants influence response to celecoxib for prevention of colorectal adenoma.
Andrew T Chan, Ann G Zauber, Meier Hsu, Aurora Breazna, David J Hunter, Craig J Eagle

Gastroenterology· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.
Monica M Bertagnolli, Craig J Eagle, Ann G Zauber, Mark Redston, Aurora Breazna

Cancer Prev Res (Phila)· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aberrant crypt foci in the adenoma prevention with celecoxib trial.
Nancy L Cho, Mark Redston, Ann G Zauber, Adelaide M Carothers, Jason Hornick, Craig J Eagle

Cancer Prev Res (Phila)· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review.
Delia Schaffer, Timothy Florin, Craig Eagle, Ian Marschner, Gurkirpal Singh

Med J Aust· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas.
Scott D Solomon, Marc A Pfeffer, John J V McMurray, Rob Fowler, Peter Finn, Craig Eagle

Circulation· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celecoxib for the prevention of sporadic colorectal adenomas.
Monica M Bertagnolli, Craig J Eagle, Ann G Zauber, Mark Redston, Scott D Solomon

N Engl J Med· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celecoxib for the prevention of colorectal adenomatous polyps.
Nadir Arber, Craig J Eagle, Julius Spicak, István Rácz, Petr Dite

N Engl J Med· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis